Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study

Figure 3

Ranking the five studied doublets for tumor response and hematological AEs in 1691 included patients. a. Early treatment discontinuation. b. Treatment failure. c. Any hematological AE. d. Leukopenia. e. Anemia. f. Neutropenia. g. Thrombocytopenia. Abbreviations: AE, adverse event; OR, odds ratio; G-CSF, granulocyte colony-stimulating factor; EPO, erythropoietin; IL-11, interleukin 11; ECOG, Eastern Cooperative Oncology Group; TPO, thrombopoietin. Note: Only baseline variables with significant OR and the studied doublets were displayed in graphs.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us